共 50 条
- [32] GENERAL PHARMACOLOGICAL PROPERTIES OF UFT, A NEW TYPE OF ANTICANCER AGENT CONSISTING OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL (FT) AND URACIL .1. PHARMACOLOGICAL ANALYSIS OF THE COMBINED EFFECT OF FT AND URACIL ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1981, 31-2 (08): : 1268 - 1278
- [35] STUDIES ON COMBINATION THERAPY WITH 1-(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL PLUS URACIL .2. EFFECTS OF URACIL ON INVITRO METABOLISMS OF 1-(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL AND 5-FLUOROURACIL CHEMOTHERAPY-TOKYO, 1981, 29 (02): : 176 - 184
- [39] RAPID-DETERMINATION OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL IN HUMAN-BLOOD BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY JOURNAL OF CHROMATOGRAPHY, 1978, 146 (03): : 518 - 521
- [40] STUDIES ON FATE OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL (FT-207), A CARCINOSTATIC AGENT .3. ABSORPTION, DISTRIBUTION, EXCRETION AND METABOLISM AFTER RECTAL ADMINISTRATION OF FT-207 YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1975, 95 (06): : 732 - 740